TREATMENT STRATEGIES FOR EXTENSION OF LEVODOPA EFFECT

被引：22

作者：

LEWITT, PA ^{[1
]}

机构：

[1] WAYNE STATE UNIV, DETROIT, MI 48202 USA

来源：

NEUROLOGIC CLINICS | 1992年 / 10卷 / 02期

关键词：

D O I：

10.1016/S0733-8619(18)30224-X

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：511 / 526

页数：16

共 112 条

[61]

MARREL C, 1985, EUR J MED CHEM, V20, P467

[62]

MARSDEN CD, 1977, LANCET, V1, P345

[63]

MARSDEN CD, 1987, EUR NEUROL S1, V27, P1

[64] PLASMA DOPA CONCENTRATIONS AFTER DIFFERENT PREPARATIONS OF LEVODOPA IN NORMAL SUBJECTS [J].

MORRIS, JGL ;

PARSONS, RL ;

TROUNCE, JR ;

GROVES, MJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (06) :983-990

[65] HEAD-INJURY AS A RISK FACTOR FOR ALZHEIMERS-DISEASE [J].

MORTIMER, JA ;

FRENCH, LR ;

HUTTON, JT ;

SCHUMAN, LM .

NEUROLOGY, 1985, 35 (02) :264-267

[66]

MUENTER MD, 1977, MAYO CLIN PROC, V52, P163

[67] PHARMACODYNAMIC MODELING OF CONCENTRATION-EFFECT RELATIONSHIPS AFTER CONTROLLED-RELEASE CARBIDOPA LEVODOPA (SINEMET-CR4) IN PARKINSONS-DISEASE [J].

NELSON, MV ;

BERCHOU, RC ;

LEWITT, PA ;

KARETI, D ;

GALLOWAY, MP .

NEUROLOGY, 1990, 40 (01) :70-74

[68] PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF L-DOPA PLASMA-CONCENTRATIONS AND CLINICAL EFFECTS IN PARKINSONS-DISEASE AFTER SINEMET [J].

NELSON, MV ;

BERCHOU, RC ;

LEWITT, PA ;

KARETI, D ;

KESAREE, N ;

SCHLICK, P ;

GALLOWAY, MP .

CLINICAL NEUROPHARMACOLOGY, 1989, 12 (02) :91-97

[69] CLINICAL AND BIOCHEMICAL-STUDIES WITH CONTROLLED-RELEASE LEVODOPA CARBIDOPA [J].

NUTT, JG ;

WOODWARD, WR ;

CARTER, JH .

NEUROLOGY, 1986, 36 (09) :1206-1211

[70] LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS [J].

NUTT, JG ;

WOODWARD, WR .

NEUROLOGY, 1986, 36 (06) :739-744

← 2 3 4 5 6 7 8 9 10 11 →